TY  - JOUR

T1  - Assessing the value of new antimicrobials: evaluations of cefiderocol and ceftazidime-avibactam to inform delinked payments by the NHS in England

JO  - Applied Health Economics and Health Policy

UR  - https://eprints.whiterose.ac.uk/id/eprint/220473

PY  - 2024/11/30

AU  - Woods B

AU  - Kearns B

AU  - Schmitt L

AU  - Jankovic D

AU  - Rothery C

AU  - Harnan S

AU  - Hamilton J

AU  - Scope A

AU  - Ren S

AU  - Bojke L

AU  - Wilcox M et al

ED  - 

DO  - DOI: 10.1007/s40258-024-00924-x

PB  - Springer Science and Business Media LLC

Y2  - 2024/12/26

ER  -